More PRNewswire
View Older Stories View Newer Stories-
ValGenesis VLMS to Drive Digital Transformation for Leading Spanish Pharmaceutical Company
-
Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Argyle Real Estate Partners Enters Charleston MSA with the Acquisition of Newbrook Point Hope
-
The Path Ahead: Getting to Know One Another Better
-
CHIPOTLE AND STRAVA TEAM UP TO HELP FANS ACHIEVE WELLNESS GOALS ALL JANUARY
-
Pomvom Ltd. and Israel Acquisitions Corp. Announce Definitive Business Combination Agreement, Bringing the Leading Experiential Content Company to the Nasdaq
-
Immorta Bio Announces Personalized Progenitor Cell Platform for Organ Specific Regeneration
-
Introducing Hockey Cares: Supporting Those in Need from the Delaware Valley Amateur Hockey Community
-
BioMatrix Specialty Pharmacy Announces Kathee Kramm as CEO
-
NeuroBo to Participate in Industry and Investor Conferences in January
-
Leaders of the Protect Yunus Campaign and Civic Courage Express Deep Concern Over the Prison Sentence for Nobel Laureate Muhammad Yunus
-
CARDIOMECH RAISES $13M IN HEAVILY OVERSUBSCRIBED ROUND FOR ITS TRANSCATHETER MITRAL CHORDAL REPAIR TECHNOLOGY
-
CSL Behring Demonstrates Continued Commitment to Alpha-1 Community with Addition of ZEMAIRA® [Alpha1-Proteinase Inhibitor (Human)] 4- and 5-Gram Vials
-
Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024
-
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
BEN E. KEITH COMPANY ANNOUNCES EXECUTIVE LEADERSHIP CHANGES
-
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors
-
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools
-
Kindbody to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
-
CGBio's 'NOVOSIS PUTTY' Receives FDA 'Breakthrough Device Designation,' Accelerate Entry into the US Market
-
JJ's House Joins Forces with Sisters in the Fight Breast Cancer Foundation to Make Survivors Feel Beautiful
-
LAZYDAYS ANNOUNCES $35 MILLION MORTGAGE LOAN FACILITY
-
ARA PARTNERS ACQUIRES MAJORITY INTEREST IN USD CLEAN FUELS
-
ORANGE COUNTY REGISTER NAMES SOUTH COAST COMMUNITY SERVICES A WINNER OF THE ORANGE COUNTY TOP WORKPLACES 2023 AWARD
-
MAPS PBC Announces New American Medical Association CPT III Codes for Psychedelic-Assisted Therapies Take Effect
-
Frontage announces the appointment of Mr. Henry Gao as President of Asia Pacific
-
Founder and CEO of The Lovesac Company Publishes Candid Origin Story
-
If you are a dentist or orthodontist who purchased Invisalign directly from Align, a class action lawsuit may affect your rights
-
Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease
-
Trojan Technologies Awarded EcoVadis Gold Medal
-
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Lightstone Value Plus REIT II, Inc. Announces Extension of the Expiration Date for Tender Offer to Monday, February 5, 2024
-
Synchrony to Announce Fourth Quarter 2023 Financial Results on January 23, 2024
-
Former Fortune 500 CEO Authors Guide for Simplifying Business
-
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
-
Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
-
Actinium Announces Acceptance of Five Abstracts for Presentation at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®
-
Omnicom Announces Closing of Acquisition of Flywheel
-
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024
-
RUSSEL METALS ANNOUNCES CHANGES TO THE BOARD OF DIRECTORS
-
DwyerOmega Acquires Assets of Miljoco Corp. LLC
-
DISH Network Convertible Notes Become Convertible Into Shares of EchoStar Corporation
-
Agriculture & Natural Solutions Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing January 2, 2024
-
South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials
-
Emissary Launches Innovative Sales Intelligence Platform, Emissary Knowledge, Giving Sales Leaders an Information Advantage.
-
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
-
SIGRID Partners With Pure Pharmacy as its Exclusive Miami Retailer
-
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings
-
Hydro One Limited announces search for a new Chief Financial Officer as Chris Lopez intends to step down on June 30, 2024
-
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
